CNTG - Centogene N.V.

QQQ $ 452.69 $ -0.78 (-0.17 %)

DIA $ 399.39 $ -0.25 (-0.06 %)

SPY $ 529.44 $ -0.48 (-0.09 %)

TLT $ 92.05 $ -0.34 (-0.37 %)

GLD $ 220.19 $ 0.18 (0.08 %)

Previous Close

$ 0.4

Open

$ 0.44

Bid

$ 0.38 x 100

Ask

$ 0.00 x 0

Day's Range

$ 0.40 - $ 0.45

52 Week Range

$ 0.36 - $ 1.98

Volume

1,077,651

Average Volume

Market Cap

11.04M

Beta (5Y Monthly)

$ 0.33

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Centogene shares are trading higher after ...
05/16/2024 12:18:37

CENTOGENE FY23 EPS €(1.27) Vs €(1.19); Rev...
05/15/2024 21:20:24

CENTOGENE Entered Into Agrements With Life...
05/15/2024 21:11:26

CENTOGENE And Evotec Announce Discovery Of...
05/14/2024 12:53:09

CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies...

why-wang--lee-group-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket

Why Wang & Lee Group Shares Are Trading Hi...
04/19/2024 09:45:48

Centogene Receives Non-Compliance Notifica...
04/02/2024 20:32:08

In accordance with Listing Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a period of 180 calendar days from t...

CENTOGENE Extends Strategic Partnership Wi...
03/19/2024 10:32:07

Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases...

CENTOGENE Collaborates On Research Publish...
02/29/2024 22:07:59

CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and ne...

Centogene Reveals Receipt Of Nasdaq Notice...
02/28/2024 11:37:56

Centogene Says It Is Exploring A Range Of ...
02/28/2024 11:33:34

The company received a staff determination letter (the "Letter") on Feb. 27, 2024, from the Listing Qualifications Depa...

Centogene And The Laboratory Of Human Gene...
01/25/2024 11:48:18

As part of the collaboration, CENTOGENE and the Lab will leverage the CENTOGENE Biodatabank, which contains over 70 million uni...

Centogene Has Been Recognized By French Mi...
01/24/2024 11:33:48

Centogene And Michael J. Fox Foundation Fo...
01/23/2024 11:39:14

Centogene Announced Preliminary Unaudited ...
01/18/2024 11:32:45

Centogene Says Reached Its Initial Recruit...
12/13/2023 11:32:23

Having met this milestone, CENTOGENE will continue to work with its extensive network of 30,000 physicians and enroll patients ...

Centogene Expands Multiomic Diagnostic Por...
10/10/2023 10:34:31

Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases...

Centogene Reports H1 Total Revenues Increa...
09/07/2023 21:18:41

Centogene Announced Data Confirming The Ut...
09/01/2023 12:03:56

CENTOGENE Receives Nasdaq Non-Compliance N...
08/31/2023 20:32:58

Centogene N.V. (NASDAQ:CNTG) ("we" or the "Company"), the essential life science partner for data-driven answe...

Centogene Regains Compliance With Nasdaq L...
07/14/2023 10:33:55